Using a model of inducible hyperglucagonemia caused by mTORC1 activation in α cells, our studies uncovered a potentially novel biphasic response characterized by an early phase of glucose intolerance followed by a phase of reduction in liver glucagon action and restoration of glucose tolerance. This evidence concerns the gene GCG and Glucose intolerance.